Interests

• Pharmaceutical science

• Genetic Engineering

• Molecular Biology

Mehraveh Hosseinali

M.Sc. Candidate

Mehraveh is currently a M.Sc. student at the University of Waterloo, working with the Theraphage Lab. She completed her B.Sc. in Applied Chemistry at Sharif University of Technology in Tehran. Her MS.C. project focuses on engineering AAV particles in E. coli to encapsulate a gene of interest as a novel gene therapy platform. She will design a novel production method that includes separate processes for AAV capsid production and genetic material production, followed by in vitro assembly in E. coli to generate complete AAV particles. She is also working on the optimization and characterization of a novel anelloviral vector production system for a gene therapy platform.

Education

• B.Sc. Applied Chemistry, Sharif University of Technology, Iran (2022)

Contact

• mehraveh.hosseinali@theraphage.bio

• mehraveh.hosseinali@uwaterloo.ca

PUBLICATIONS:

• Siavashy, S., Soltani, M., Rahimi, S., Hosseinali, M., Guilandokht, Z., & Raahemifar, K. (2024). Recent Advancements in Microfluidic-based Biosensors for Detection of Genes and Proteins: Applications and Techniques. Biosensors and Bioelectronics: X, 100489.

Presentations:

• Prakash, R., Pushparajah, D., Cheung, S., Hosseinali, M., Lumini, J., Slavcev, R. (Presented by Julia Lumini & Roderick Slavcev). An E. coli-based platform for the production and assembly of anellovirus vectors in vitro for gene therapy platform. Poster presented at: American Society of Gene and Cell Therapy 28th Annual Meeting. 2025, May 13. New Orleans, Louisiana